CMV p65 Antikörper
-
- Target Alle CMV p65 Produkte
- CMV p65 (Cytomegalovirus p65 (CMV p65))
-
Reaktivität
- Human Herpesvirus 5 (HHV-5)
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CMV p65 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunofluorescence (IF), Coating (Coat), Immunocytochemistry (ICC)
- Aufreinigung
- Purified by Protein A/G
- Immunogen
- Recombinant CMV-p65 protein
- Klon
- CMV101
- Isotyp
- IgG1 kappa
-
-
- Applikationshinweise
-
Positive Control: CMV-infected cells. Tissues.
Known Application: ELISA (For coating, order Ab without BSA), Immunocytochemistry (Acetone or paraformaldehyde fixed) (0.5-1 μg/mL for 30 min), Immunofluorescence (0.5-1 μg/mL), Optimal dilution for a specific application should be determined.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 200 μg/mL
- Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
- Haltbarkeit
- 24 months
-
- Target
- CMV p65 (Cytomegalovirus p65 (CMV p65))
- Andere Bezeichnung
- Cytomegalovirus p65 (CMV-p65) (CMV p65 Produkte)
- Substanzklasse
- Viral Protein
- Hintergrund
- Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
- Molekulargewicht
- 65kDa
-